Sp1275
INTEGRATING NEW TECHNOLOGY IN THE MANAGEMENT OF NON-DYSPLASTIC BARRETT'S ESOPHAGUS PATIENTS - A CASE-BASED DISCUSSION WITH DR. JOHN LIPHAM, DR. RAMAN MUTHUSAMY & DR. HARSHIT KHARA
Date
May 7, 2023
Society: DDW
A case-based panel discussion regarding integrating new technology in the management of non-dysplastic Barrett's esophagus patients. Sponsored by Castle Biosciences
A case-based panel discussion regarding integrating new technology in the management of non-dysplastic Barrett's esophagus patients. Sponsored by Castle Biosciences
Presenter
Speakers
University of California, Los Angeles
Tracks
Related Products
THE TISSUE SYSTEMS PATHOLOGY TEST ENABLES RISK-ALIGNED MANAGEMENT FOR PATIENTS WITH BARRETT’S ESOPHAGUS
INTRODUCTION: The goal of Barrett’s esophagus (BE) surveillance is to detect dysplasia and esophageal adenocarcinoma (EAC) at early, treatable stages…
TRENDS AND OUTCOMES OF INTRAOPERATIVE ESOPHAGOGASTRODUODENOSCOPY DURING MINIMALLY INVASIVE HELLER MYOTOMY: A NSQIP ANALYSIS
The aim of this study was to assess the association between interval between nCRT and
LONG-TERM PATIENT REPORTED OUTCOMES AFTER MAGNETIC SPHINCTER AUGMENTATION
Introduction: Gastroesophageal reflux disease is one of the most common gastrointestinal disorders worldwide. Magnetic sphincter augmentation (MSA, LINX®) is a safe and effective surgical treatment for GERD that obtained FDA approval in 2012. Long-term outcomes of MSA are limited…
ENDOSCOPIC APPLICATION OF PULSED ELECTRIC FIELD IN DUODENUM FOR IMPROVING GLYCEMIC CONTROL IN PATIENTS WITH TYPE 2 DIABETES—A PROSPECTIVE FEASIBILITY STUDY
Type II diabetes (T2D) pathogenesis is linked with diabetes-associated duodenal alterations, presenting a potential regnerative therapeutic target…
